Suning Chen Selected Research

Suning Chen Research Topics

Disease

34	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2024 - 01/2007
29	Neoplasms (Cancer) 03/2024 - 06/2005
22	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2024 - 02/2010
19	Leukemia 03/2024 - 06/2005
16	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 02/2024 - 02/2014
11	Breast Neoplasms (Breast Cancer) 04/2024 - 08/2011
9	Aplastic Anemia (Anemia, Hypoplastic) 01/2022 - 11/2014
8	Residual Neoplasm 03/2024 - 02/2010
7	Infections 05/2024 - 01/2014
7	Graft vs Host Disease (Graft-Versus-Host Disease) 05/2024 - 01/2014
6	Philadelphia Chromosome 10/2023 - 08/2013
5	Hematologic Neoplasms (Hematological Malignancy) 03/2024 - 10/2013
5	Chromosome Aberrations (Chromosome Abnormalities) 12/2019 - 11/2002
4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 02/2024 - 11/2014
4	Eosinophilia 01/2023 - 01/2017
4	Multiple Myeloma 01/2022 - 04/2011
3	Viremia 03/2024 - 07/2021
3	Lymphoma (Lymphomas) 01/2022 - 04/2015
3	Blast Crisis (Blast Phase) 09/2014 - 12/2010
2	B-Cell Lymphoma (Lymphoma, B Cell) 10/2022 - 10/2022
2	Acute Promyelocytic Leukemia 12/2021 - 01/2019
2	Colitis 07/2021 - 01/2018
2	Pathologic Complete Response 01/2019 - 01/2017
2	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 01/2019 - 11/2014
1	Adenoviridae Infections (Adenovirus Infections) 05/2024
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 05/2024
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 05/2024
1	Critical Illness (Critically Ill) 01/2024
1	Jaundice (Icterus) 06/2023
1	Cytokine Release Syndrome 01/2023
1	Pain (Aches) 01/2023

Drug/Important Bio-Agent (IBA)

10	Imatinib Mesylate (Gleevec)FDA Link 02/2024 - 12/2010
8	Messenger RNA (mRNA)IBA 09/2023 - 10/2008
8	Tyrosine Kinase InhibitorsIBA 01/2023 - 12/2013
7	Chimeric Antigen ReceptorsIBA 10/2023 - 01/2020
7	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2007
6	ruxolitinibIBA 01/2023 - 01/2021
5	venetoclaxIBA 03/2024 - 01/2022
5	nilotinib FDA Link 02/2024 - 01/2015
5	RNA (Ribonucleic Acid)IBA 01/2023 - 08/2014
5	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 12/2021 - 01/2016
5	MicroRNAs (MicroRNA)IBA 01/2017 - 02/2013
4	Lapatinib (GW572016)FDA Link 02/2016 - 08/2011
3	Core Binding Factors (Core-Binding Factor)IBA 10/2023 - 01/2021
3	olverembatinibIBA 01/2023 - 01/2022
3	EnzymesIBA 12/2022 - 12/2011
3	Tadalafil (Cialis)FDA Link 12/2022 - 01/2022
3	Biomarkers (Surrogate Marker)IBA 10/2022 - 02/2013
3	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2022 - 04/2017
3	AntigensIBA 02/2017 - 01/2014
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 11/2015 - 08/2011
3	DNA (Deoxyribonucleic Acid)IBA 08/2014 - 06/2005
2	Rituximab (Mabthera)FDA Link 05/2024 - 01/2020
2	SteroidsIBA 05/2024 - 01/2023
2	blinatumomabIBA 04/2024 - 03/2024
2	6-methyladenineIBA 04/2024 - 01/2022
2	nuclear pore complex protein 98IBA 02/2024 - 05/2010
2	CytokinesIBA 01/2023 - 03/2019
2	Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)IBA 12/2022 - 04/2022
2	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 01/2022 - 10/2017
2	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 07/2021 - 01/2017
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 07/2021 - 01/2017
2	Estrogen ReceptorsIBA 01/2021 - 03/2014
2	bafilomycin A1IBA 01/2020 - 03/2015
2	Hemoglobins (Hemoglobin)IBA 03/2019 - 01/2015
2	AcidsIBA 01/2019 - 01/2015
2	Transcription Factors (Transcription Factor)IBA 01/2018 - 04/2015
2	Phosphotransferases (Kinase)IBA 02/2016 - 08/2011
2	BerberineIBA 01/2016 - 01/2014
2	Decitabine FDA Link 12/2015 - 11/2014
2	Glucose (Dextrose)FDA LinkGeneric 06/2015 - 12/2013
2	Tamoxifen FDA LinkGeneric 09/2014 - 03/2014
2	Metformin (Glucophage)FDA LinkGeneric 03/2014 - 12/2013
2	Tyrosine (L-Tyrosine)FDA Link 02/2014 - 08/2011
2	Codon (Codons)IBA 11/2008 - 06/2005
1	Immune Checkpoint InhibitorsIBA 05/2024
1	Paclitaxel (Taxol)FDA LinkGeneric 04/2024
1	Foscarnet FDA LinkGeneric 03/2024
1	Valganciclovir FDA Link 03/2024
1	Azacitidine (5 Azacytidine)FDA Link 03/2024
1	palbociclibIBA 03/2024
1	flumatinibIBA 02/2024
1	Dasatinib (BMS 354825)FDA Link 02/2024
1	HLA Antigens (Human Leukocyte Antigens)IBA 02/2024
1	BilirubinIBA 06/2023
1	Basiliximab FDA Link 01/2023
1	Antineoplastic Agents (Antineoplastics)IBA 01/2023

Therapy/Procedure

29	Hematopoietic Stem Cell Transplantation 05/2024 - 02/2010
25	Therapeutics 05/2024 - 12/2010
13	Drug Therapy (Chemotherapy) 05/2024 - 12/2010
10	Transplantation 05/2024 - 09/2014
7	Stem Cell Transplantation 02/2024 - 01/2020
2	Immunotherapy 05/2024 - 01/2023
2	Cell Transplantation 03/2024 - 12/2021
2	Induction Chemotherapy 12/2023 - 11/2021
2	Subcutaneous Injections 04/2011 - 06/2005
1	Haploidentical Transplantation 05/2024
1	Bridge Therapy 01/2023
1	Drug Tapering 01/2023
1	Salvage Therapy 01/2023